Quick Answer
IDEAYA Biosciences, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $218.71 million for the year ending 2025.
- IDEAYA Biosciences, Inc. showed an increase of +3,024.4% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from IDEAYA Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $218.71 million | Fiscal year 2024: $7.00 million | Fiscal year 2023: $23.39 million | Fiscal year 2022: $50.93 million | Fiscal year 2021: $27.94 million | Fiscal year 2020: $19.54 million | Fiscal year 2019: $0.00.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: